What about HER-Vaxx that made you question them???? IMU haven't put a step foot wrong with the clinical trials for the last few year, it's not their fault the market hasn't valued any of the development. The market is clearly waiting for clinical trial updates for VAXINIA and especially OASIS.
IMU Price at posting:
3.1¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)